GRATTAN AND HYNDS LIMITED
Company number SC119987 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Grattan and Hynds Limited
1. Financial Health Score: F
Critical Condition – The patient is in financial distress. The company has been technically insolvent for seven consecutive years, with liabilities exceeding assets by £265,265 as of July 2025. Cash reserves have withered to just £4,735, while short-term debts stand at £752,846. This is a business surviving on life support – dependent on the circulatory system of group funding rather than its own financial vitality.
2. Key Vital Signs
| Vital Sign | 2025 | 2024 | Interpretation |
|---|---|---|---|
| Net Assets | -£265,265 | -£268,500 | Chronic insolvency – liabilities exceed assets by a significant margin |
| Cash Position | £4,735 | £6,138 | Dangerously low – barely enough to cover a week's operations |
| Current Liabilities | £752,846 | £556,279 | Rapidly deteriorating – increased by 35% in one year |
| Net Current Assets | -£266,936 | -£262,526 | Severe working capital deficit – cannot meet short-term obligations |
| Shareholders' Funds | -£265,365 | -£268,600 | Deeply negative equity position |
| Debtors | £481,175 | £287,615 | Significant increase – but quality is questionable |
Vital Sign Analysis
Blood Pressure (Liquidity): Dangerously low. The current ratio is approximately 0.65:1 (current assets of £485,910 against current liabilities of £752,846). Healthy businesses maintain a ratio above 1.5:1. This company cannot meet its short-term obligations from its current resources – the equivalent of a patient whose blood pressure has dropped to levels where organs begin to fail.
Pulse (Cash Flow): Weak and irregular. Cash has declined from £6,138 to £4,735 – a 23% drop. For a company with nearly £750,000 in current liabilities, holding less than £5,000 in cash suggests the business is operating hand-to-mouth, with no financial reserves to absorb any shock.
Cholesterol (Debt Burden): Critically high. The company carries £752,846 in current liabilities against only £485,910 in current assets. The banking facilities are secured by a floating charge over the whole assets – meaning the bank has first claim on everything. Other creditors have ballooned from £151,852 to £532,852 – a 251% increase.
Temperature (Profitability): Difficult to diagnose precisely as no profit and loss account is filed. However, the slight improvement in net assets (from -£268,500 to -£265,265) suggests a small profit of approximately £3,235 may have been made. This is negligible in the context of the overall debt burden.
3. Diagnosis
Primary Condition: Chronic Insolvency
The company has operated with negative net assets since at least 2018. This is not an acute crisis but a long-term chronic condition. The trajectory shows:
- 2016-2017: The company was healthy, with positive net assets of £25,425 and £92,666 respectively
- 2018 onwards: A deterioration set in, with net assets turning negative and remaining so for seven consecutive years
- 2023: A massive restructuring occurred – total assets jumped from £854,007 to £1,968,460, but liabilities increased proportionately, suggesting group reorganisation rather than genuine growth
- 2024: A prior period adjustment of £242,259 further eroded equity, indicating historical accounting issues that made the true position worse than previously reported
Complications
Group Dependency: The debtors figure of £481,175 includes £321,151 (67%) owed by group undertakings. This is the financial equivalent of relying on a family transfusion – the company appears to be sustained by inter-company funding rather than generating sufficient cash from its own operations.
Tax Liability: £211,660 is owed for taxation and social security. This is a priority debt that cannot be deferred indefinitely and represents a significant claim on future cash flows.
Creditor Concentration: Other creditors of £532,852 have increased dramatically. This suggests suppliers and other trade creditors are financing the company's operations – a precarious position that can unravel quickly if confidence is lost.
Minimal Tangible Assets: Net tangible fixed assets of just £2,228 provide almost no collateral beyond what is already secured to the bank.
Going Concern Risk
The accounts were prepared on a going concern basis, which implies the directors believe the company can continue trading. This typically requires disclosed support from creditors or group entities. The company's survival depends on:
- Continued support from group undertakings (who are significant debtors)
- Creditors not demanding immediate payment
- The bank not enforcing its floating charge
- The company generating sufficient cash from plastering operations
4. Recommendations
Immediate Treatment (0-3 months)
-
Cash Flow Resuscitation: Pursue collection of the £321,151 owed by group undertakings with urgency. This represents the most accessible source of liquidity.
-
Creditor Negotiation: Engage proactively with HMRC regarding the £211,660 tax liability. A Time to Pay arrangement may be necessary to prevent enforcement action.
-
Working Capital Review: The 251% increase in other creditors requires immediate investigation. Understand whether this represents trade creditors being stretched, director loans, or group liabilities.
Medium-Term Rehabilitation (3-12 months)
-
Profitability Assessment: As a plastering subcontractor with only 2 employees, the company must evaluate whether its contract pricing generates sufficient margin. The minimal profit implied by the 2025 accounts (£3,235) is insufficient to service the debt burden.
-
Group Structure Evaluation: Given the significant inter-company balances, the group's overall financial position should be assessed. If the group is strong, formal support arrangements should be documented to substantiate the going concern basis.
-
Debt Restructuring: Explore whether group-level refinancing could reduce the interest burden and provide more manageable repayment terms.
Long-Term Wellness (12+ months)
-
Strategic Review: Consider whether the company's role within the group justifies its continuation as a separate entity. If it functions primarily as a vehicle for group contracts, consolidation may be more efficient.
-
Capital Injection: The negative equity of £265,265 requires a significant capital injection to restore the balance sheet to health. Without this, the company remains vulnerable to any disruption.
-
Director Responsibilities: Directors should carefully document their going concern assessment and ensure they are not trading whilst insolvent. The duty to creditors becomes paramount when a company is in this financial condition.
Risk Indicators Summary
| Risk Factor | Severity | Trend |
|---|---|---|
| Insolvency | Critical | Chronic – persistent over 7 years |
| Cash Reserves | Critical | Declining – 23% drop in one year |
| Creditor Dependence | High | Worsening – current liabilities up 35% |
| Group Dependency | High | Increasing – 67% of debtors are group-related |
| Tax Exposure | High | £211,660 owed to HMRC |
| Going Concern | Significant | Dependent on external support |